Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Metrics to compare | BDMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBDMDPeersSector | |
---|---|---|---|---|
P/E Ratio | 4.6x | −10.1x | −0.5x | |
PEG Ratio | 0.26 | −0.29 | 0.00 | |
Price/Book | 1.5x | 3.3x | 2.6x | |
Price / LTM Sales | 1.6x | 4.3x | 3.2x | |
Upside (Analyst Target) | - | 62.6% | 40.5% | |
Fair Value Upside | Unlock | −8.6% | 4.4% | Unlock |